ChatGPT-Medical guidance

The purpose of this study was to assess ChatGPT's ability and its potential risks in medical guidance for patients with MAFLD. The study was conducted in February 2023. We simulated the questions raised by patients with MAFLD, and tested 110 questions in six aspects, including concept, diagnosis, progression, prevention, treatment and comorbidity. Each question was submitted to ChatGPT three times. Appropriateness and consistency were evaluated. In the data set, we presented the questions and corresponding answers. Judgments for consistency and appropriateness and reasons were also provided.本研究旨在评估ChatGPT在为代谢相关脂肪性肝病（Metabolic Dysfunction-Associated Fatty Liver Disease，MAFLD）患者提供医疗指导时的能力及其潜在风险。本研究于2023年2月开展。我们模拟了MAFLD患者提出的相关问题，从概念、诊断、疾病进展、预防、治疗及合并症六个维度共设置110道测试题，并将每道题提交给ChatGPT三次进行应答。研究对ChatGPT回复的恰当性与一致性进行了评估。本数据集收录了上述测试题及其对应的应答内容，同时提供了关于回复恰当性与一致性的判定结果及判定依据。

搜集汇总

背景与挑战

背景概述

该数据集旨在评估ChatGPT在代谢相关脂肪性肝病（MAFLD）患者医疗指导中的能力和风险，包含模拟患者提出的110个问题，覆盖概念、诊断、进展、预防、治疗和共病六个方面。每个问题被提交给ChatGPT三次，评估回答的适当性和一致性，重点关注对患者医疗行为的影响，为人工智能在医疗领域的应用提供实证研究。